| Title | Publication Date | Publication | Categories | Link | hf:doc_categories |
|---|---|---|---|---|---|
| Revolutionizing Multiple System Atrophy Diagnosis With Amprion’s Synuclein Seed Amplification Assay: Russell Lebovitz, MD, PhD | December 18, 2024 | Neurology Live | Video | video | |
| Sensitivity and specificity of a seed amplification assay for diagnosis of multiple system atrophy: a multicentre cohort study | November 21, 2024 | The Lancet Neurology | Scientific paper | scientific-paper | |
| Amprion Announces Landmark Study in The Lancet Neurology | November 21, 2024 | Businesswire | Press release | press-release | |
| New Biomarkers for Better Neurodegenerative Disease Diagnostics and Treatments | November 14, 2024 | Today’s Clinical Lab | News article | news-article | |
| Association of CSF α-synuclein seed amplification assay positivity with disease progression and cognitive decline: A longitudinal Alzheimer’s Disease Neuroimaging Initiative study | October 20, 2024 | Alzheimer’s & Dementia | Scientific paper | scientific-paper | |
| Amprion Honored to Win the 2024 BioTech Breakthrough Award ‘Clinical Diagnostics Solution of the Year’ | November 19, 2024 | Businesswire | Press release | press-release | |
| α-Synuclein seed amplification technology for Parkinson’s disease and related synucleinopathies | July 1, 2024 | Trends in Biotechnology | Literature review | literature-review | |
| α-Synuclein Seed Amplification in CSF and Brain from Patients with Different Brain Distributions of Pathological α-Synuclein in the Context of Co-Pathology and Non-LBD Diagnoses | July 29, 2024 | Annals of Neurology | Scientific paper | scientific-paper | |
| α-Synuclein seed amplification assay shows potential to unmask pathology and enable biologically-based therapeutic development | June 1, 2023 | Movement Disorders | Position paper | position-paper | |
| α-Synuclein seed amplification assay detects Lewy body co-pathology in autosomal dominant Alzheimer’s disease late in the disease course and dependent on Lewy pathology burden | April 26, 2024 | Alzheimer’s & Dementia | Scientific paper | scientific-paper | |
| Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies | April 27, 2024 | Acta Neuropathologica Communications | Scientific paper | scientific-paper | |
| SYNTap Biomarker Test helps doctors distinguish Parkinson’s Disease from Parkinsonism in early stages | April 6, 2022 | PR Web | Press release | press-release | |
| Structures of α-synuclein filaments from human brains with Lewy pathology | September 15, 2022 | Nature | Scientific paper | scientific-paper | |
| Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson’s disease and dementia with Lewy bodies | April 7, 2021 | Acta Neuropathologica Communications | Scientific paper | scientific-paper | |
| Seed amplification assay results illustrate discrepancy in Parkinson’s disease clinical diagnostic accuracy and error rates | August 17, 2023 | Journal of Neurology | Scientific paper | scientific-paper | |
| Revolutionizing Dementia Research With Synuclein Biomarker Tests | August 31, 2023 | Neurology Live | News article | news-article | |
| Revised criteria for diagnosis and staging of Alzheimer’s disease: Alzheimer’s Association Workgroup | June 27, 2024 | Alzheimer’s & Dementia | Position paper | position-paper | |
| Rapid and ultra-sensitive quantitation of disease-associated α-synuclein seeds in brain and cerebrospinal fluid by αSyn RT-QuIC | February 9, 2018 | Acta Neuropathologica Communications | Scientific paper | scientific-paper | |
| Parkinson’s is often misdiagnosed. New tests may change that. | October 10, 2024 | Washington Post | News article | news-article | |
| NIH Researchers to Use Amprion CSF Test in Dementia Biomarker Validation Study | August 24, 2023 | Precision Medicine Online | News article | news-article | |
| New test detects Parkinson’s biomarker before movement symptoms start | April 18, 2023 | Fierce Biotech | News article | news-article | |
| New Paper Published in Alzheimer’s: Dementia: The Journal of the Alzheimer’s Association, Demonstrates Correlation Between the Presence of Misfolded α-Synuclein and Clinical Presentations of Alzheimer’s Disease | February 9, 2024 | PR Newswire | Press release | press-release | |
| New Insights On Alzheimer’s And What It Means For Personalized Medicine | January 19, 2022 | PR Web | Press release | press-release | |
| New Assay Hailed as a Game Changer for Early Parkinson’s Dx | April 13, 2023 | Medscape | News article | news-article | |
| Multiple biomarkers improve diagnostic accuracy across Lewy body and Alzheimer’s disease spectra | March 4, 2024 | Annals of Clinical and Translational Neurology | Scientific paper | scientific-paper | |
| Misfolded alpha-synuclein in amyotrophic lateral sclerosis: Implications for diagnosis and treatment | January 25, 2024 | European Journal of Neurology | Scientific paper | scientific-paper | |
| Michael J. Fox Foundation Funds Projects to Speed Development of Quantitative Biomarkers for Parkinson’s Disease | May 30, 2024 | PR Newswire | Press release | press-release | |
| Lab Test May Detect Parkinson’s Disease Even Before Symptoms Appear | April 17, 2023 | Everyday Health | News article | news-article | |
| Investigating alpha-synuclein co-pathology in Alzheimer’s disease by means of cerebrospinal fluid alpha-synuclein seed amplification assay | February 7, 2024 | Alzheimer’s & Dementia | Scientific paper | scientific-paper | |
| Investigating alpha-synuclein co-pathology in Alzheimer’s disease by means of cerebrospinal fluid alpha-synuclein seed amplification assay | February 7, 2024 | Alzheimer’s & Dementia | Scientific paper | scientific-paper | |
| How Amprion’s Test is Changing ALS, Dementia, and Parkinson’s Disease Diagnosis | September 24, 2024 | Life Sciences 360 | Podcast | podcast | |
| High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson’s disease | November 6, 2021 | Acta Neuropathologica Communications | Scientific paper | scientific-paper | |
| FDA letter supports use of new alpha-synuclein assay in trials | September 9, 2024 | Parkinson’s News Today | News article | news-article | |
| FDA Letter of Support Could Boost Use of Parkinson’s Biomarker in Clinical Trials | September 19, 2024 | 360Dx | News article | news-article | |
| FDA Issues Letter of Support for α-Synuclein Seed Amplification Assay – The Core Technology Used in Amprion’s First Commercial Test | September 5, 2024 | Business Wire | Press release | press-release | |
| FDA Issues Letter of Support for Alpha-Synuclein Seed Amplification Assay | September 5, 2024 | Clinical Lab Products | News article | news-article | |
| Exclusive: A small San Diego biotech wants to change how Parkinson’s disease is diagnosed | October 8, 2024 | Endpoints | News article | news-article | |
| Evaluation of Cerebrospinal Fluid α-Synuclein Seed Amplification Assay in Progressive Supranuclear Palsy and Corticobasal Syndrome | September 20, 2024 | Movement Disorders | Scientific paper | scientific-paper | |
| Dr. Russ Lebovitz: Revolutionizing Brain Health with Early Detection | September 26, 2024 | Life Science Success | Podcast | podcast | |
| Discriminating α-synuclein strains in Parkinson’s disease and multiple system atrophy | February 5, 2020 | Nature | Scientific paper | scientific-paper | |
| Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study | March 1, 2021 | The Lancet Neurology | Scientific paper | scientific-paper | |
| Detecting Parkinson Disease at Early Stages With Alpha-Synuclein Amplification Assay: Russell Lebovitz, MD, PhD | May 11, 2023 | Neurology Live | Video | video | |
| CSF α-Synuclein Seed Amplification Assay in Patients With Atypical Parkinsonian Disorders | August 29, 2024 | Neurology | Scientific paper | scientific-paper | |
| Clinicopathological correlation of cerebrospinal fluid alpha-synuclein seed amplification assay in a behavioral neurology autopsy cohort | March 27, 2024 | Alzheimer’s & Dementia | Scientific paper | scientific-paper | |
| Changes in the Diagnostic Process of Alzheimer Disease: A New Era of Blood-Based Approaches | December 8, 2023 | HCP Live | News article | news-article | |
| Associations between misfolded alpha-synuclein aggregates and Alzheimer’s disease pathology in vivo | September 11, 2024 | Alzheimer’s & Dementia | Scientific paper | scientific-paper | |
| Association of CSF α-Synuclein Seeding Amplification Assay Results With Clinical Features of Possible and Probable Dementia With Lewy Bodies | July 16, 2024 | Neurology | Scientific paper | scientific-paper | |
| Assessment of heterogeneity among participants in the Parkinson’s Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study | May 1, 2023 | The Lancet Neurology | Scientific paper | scientific-paper | |
| As new Alzheimer’s biomarkers come into play, here’s where the money is going | October 17, 2024 | PharmaVoice | News article | news-article | |
| Analysis of Protein Conformational Strains-A Key for New Diagnostic Methods of Human Diseases | April 17, 2020 | International Journal of Molecular Sciences | Scientific paper | scientific-paper | |
| Amprion’s αSynuclein Seed Amplification Assay to be Showcased at Alzheimer’s Association International Conference® 2023 (AAIC®) | July 15, 2023 | PR Newswire | Press release | press-release | |
| Amprion’s αSyn Seed Amplification Assay (αS-SAA) Highlighted in 10 Presentations at AD/PD™ 2024 International Conference | March 4, 2024 | PR Newswire | Press release | press-release | |
| Amprion’s Parkinson’s Disease Dx Shows Strong Performance in Study | April 26, 2023 | 360Dx | News article | news-article | |
| Amprion wins $100K to study causes of sporadic ALS | September 20, 2024 | ALS Today | News article | news-article | |
| Amprion Unveils Next-Generation SAAmplify™ Biomarker Panels to Aid in Diagnosis of Neurodegenerative Disorders at AAIC 2024 | August 1, 2024 | Technology Networks | News article | news-article | |
| Amprion Unveils Next-Generation SAAmplify™ Biomarker Panels to Aid in Diagnosis of Neurodegenerative Disorders at AAIC 2024 | July 29, 2024 | PharmiWeb | News article | news-article | |
| Amprion Unveils Next-Generation SAAmplify™ Biomarker Panels to Aid in Diagnosis of Neurodegenerative Disorders at AAIC 2024 | July 26, 2024 | Business Wire | Press release | press-release | |
| Amprion Showcases SYNTap® Biomarker Test at AD/PD™ 2023 International Conference | March 27, 2023 | PR Newswire | Press release | press-release | |
| Amprion launching SAAmplify as tool to help in disease diagnosis | August 1, 2024 | Parkinson’s News Today | News article | news-article | |
| Amprion lands new funding to advance neurodegenerative disease diagnostics | October 14, 2024 | Longevity Technology | News article | news-article | |
| Amprion Joins the Fight Against Parkinson’s Through Early Detection Testing | May 23, 2019 | PR Newswire | Press release | press-release | |
| Amprion Exhibits at MDS International Congress of Parkinson’s Disease and Movement Disorders in Madrid and Presents Scientific Insights On SYNTap® Test at Prion2022 Conference | September 15, 2022 | PR Web | Press release | press-release | |
| Amprion Clinical Laboratory Receives Accreditation from College of American Pathologists | October 27, 2021 | PR Web | Press release | press-release | |
| Amprion Awarded NIH Grant For Analytical Validation of SYNTap® Biomarker Test For Neurological Disease | May 10, 2022 | PR Web | Press release | press-release | |
| Amprion announces SYNTap™ Biomarker Test for early detection of Parkinson’s Disease (PD), Lewy Body Dementia (LBD), and Alzheimer’s Disease (AD) | October 6, 2021 | PR Web | Press release | press-release | |
| Amprion Announces Presentation of Findings Related to Usage of the αSynuclein Seed Amplification Assay in Recent Parkinson’s Study at 2023 AAN Annual Meeting | April 21, 2023 | PR Newswire | Press release | press-release | |
| Amprion Announces Initial Close of a $15M Financing to Commercialize Groundbreaking Neurologic Diagnostics | October 9, 2024 | Business Wire | Press release | press-release | |
| Amprion Announces Granting of European Patents for Seed Amplification Assay Platform | August 15, 2023 | PR Newswire | Press release | press-release | |
| Amprion Announces Collaboration with NIH Researchers on Dementia Hallmark Study | August 23, 2023 | PR Newswire | Press release | press-release | |
| Amprion Amplifies Neurological Diagnosis | February 9, 2023 | San Diego Business Journal | News article | news-article | |
| ALS Network Announces $100,000 Research Grant Awarded to Amprion, Inc. | September 12, 2024 | PR Newswire | Press release | press-release | |
| Alpha-Synuclein Testing Comes of Age | October 7, 2024 | In Vivo | Podcast | podcast | |
| Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies | August 28, 2016 | Annals of Clinical and Translational Neurology | Scientific paper | scientific-paper | |
| Alpha-Synuclein Oligomers and Neurofilament Light Chain Predict Phenoconversion of Pure Autonomic Failure | April 30, 2021 | Annals of Neurology | Scientific paper | scientific-paper | |
| Alpha-Synuclein Amplification Assay Aids Early Detection, With Potential to Improve Diagnosis and Treatment in Parkinson Disease | April 12, 2023 | Neurology Live | News article | news-article | |
| Accurate Detection of α-Synuclein Seeds in Cerebrospinal Fluid from Isolated Rapid Eye Movement Sleep Behavior Disorder and Patients with Parkinson’s Disease in the DeNovo Parkinson (DeNoPa) Cohort | February 13, 2024 | Movement Disorders | Scientific paper | scientific-paper | |
| A cross-sectional study of α-synuclein seed amplification assay in Alzheimer’s disease neuroimaging initiative: Prevalence and associations with Alzheimer’s disease biomarkers and cognitive function | May 21, 2024 | Alzheimer’s & Dementia | Scientific paper | scientific-paper | |
| A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research | February 1, 2024 | The Lancet Neurology | Literature review | literature-review | |
| A biological classification of Parkinson’s disease: the SynNeurGe research diagnostic criteria | February 1, 2024 | The Lancet Neurology | Literature review | literature-review | |
| ‘Big step forward’: New lab tests may accelerate Parkinson’s diagnosis and research | April 13, 2023 | CNN Health | News article | news-article | |
| Analysis of Protein Conformational Strains-A Key for New Diagnostic Methods of Human Diseases | April 17, 2020 | International Journal of Molecular Sciences | Scientific paper | scientific-paper | |
| ALS Network Announces $100,000 Research Grant Awarded to Amprion, Inc. | September 12, 2024 | PR Newswire | Press release | press-release |
Menu
